1. Hu, Yiyang, Gong, Chunli, Li, Zhibin, Yang, Shiming, Xiao, Yufeng. 2022. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. In Molecular cancer, 21, 34. doi:10.1186/s12943-022-01522-y. https://pubmed.ncbi.nlm.nih.gov/35114989/
2. Gallo, David, Young, Jordan T F, Fourtounis, Jimmy, Marshall, C Gary, Durocher, Daniel. 2022. CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition. In Nature, 604, 749-756. doi:10.1038/s41586-022-04638-9. https://pubmed.ncbi.nlm.nih.gov/35444283/
3. Wang, Shuang, Liu, Ximeng, Zhou, Ting, Huang, Yongbo, Li, Xu. 2022. PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity. In Cellular oncology (Dordrecht, Netherlands), 46, 195-209. doi:10.1007/s13402-022-00744-y. https://pubmed.ncbi.nlm.nih.gov/36350496/
4. Li, Jie, Lu, Jingyi, Xu, Manman, Yao, Shuzhong, Pan, Chaoyun. 2023. ODF2L acts as a synthetic lethal partner with WEE1 inhibition in epithelial ovarian cancer models. In The Journal of clinical investigation, 133, . doi:10.1172/JCI161544. https://pubmed.ncbi.nlm.nih.gov/36378528/
5. Gao, Wei, Guo, Xin, Sun, Linlin, Cao, Yinan, Zhang, Shuqun. 2024. PKMYT1 knockdown inhibits cholesterol biosynthesis and promotes the drug sensitivity of triple-negative breast cancer cells to atorvastatin. In PeerJ, 12, e17749. doi:10.7717/peerj.17749. https://pubmed.ncbi.nlm.nih.gov/39011373/
智鼠故事 
